secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0001140361-23-039417
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics appoints Gülsen Kama as CFO effective September 11, 2023; Chris Stewart resigns
--------------------------------------------------------------------------------

- Kama's base salary set at $460,000/year with 55% target bonus; receives option for 106,000 shares vesting over 4 years.
- Kama also gets a one-time $150,000 signing bonus contingent on one year of continuous employment.
- Stewart's severance includes lump sums equal to six weeks base salary, additional six weeks upon strategic milestone, and six months base salary cash.
- Stewart will consult at $500/hour through November 11, 2023, with equity vesting continuing during consulting period.
- Kama previously served as CFO of Northern Data AG and East Region & Healthcare IT CFO at Quest Diagnostics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123039417/0001140361-23-039417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123039417/brhc20057474_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-039417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer